Clinical Trials List
Protocol NumberCGHN9801
2009-12-14 - 2011-12-14
Phase II
Terminated1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Kai-Ping Chang Division of Otolaryngology
- 范綱行 Division of Radiation Therapy
- Sheng-Chieh Chan Division of Nuclear Medicine
- Cheng-Lung Hsu Division of Hematology & Oncology
- 黃祥富 Division of Otolaryngology
- Shu-Hang Ag Division of Radiology
- Li-Yu Lee Division of Others -
- 廖俊達 Division of Otolaryngology
- Tung-Chieh Chang Division of Radiation Therapy
- Tzu-Chen Yen Division of Nuclear Medicine
- Chi-Ting Liau Division of Hematology & Oncology
- Ku-How Fang Division of Otolaryngology
- 陳建誠 Division of Radiology
- 鄭恩加 長庚大學醫學院教授
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
51 participants
-
Global
0 participants
